Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

SELL
$6.08 - $8.28 $6,080 - $8,280
-1,000 Reduced 79.62%
256 $1,000
Q4 2023

Feb 14, 2024

BUY
$5.13 - $8.35 $1,610 - $2,621
314 Added 33.33%
1,256 $10,000
Q3 2023

Nov 09, 2023

BUY
$4.4 - $6.91 $4,144 - $6,509
942 New
942 $5,000
Q2 2022

Aug 11, 2022

BUY
$2.71 - $7.12 $628 - $1,651
232 New
232 $1,000
Q1 2022

May 12, 2022

SELL
$6.62 - $9.33 $59,262 - $83,522
-8,952 Closed
0 $0
Q4 2021

Feb 11, 2022

BUY
$8.3 - $11.29 $23,721 - $32,266
2,858 Added 46.9%
8,952 $78,000
Q3 2021

Nov 12, 2021

BUY
$9.73 - $13.38 $59,294 - $81,537
6,094 New
6,094 $69,000
Q2 2021

Aug 10, 2021

SELL
$9.02 - $11.68 $248,013 - $321,153
-27,496 Closed
0 $0
Q1 2021

May 12, 2021

BUY
$9.53 - $15.42 $181,308 - $293,365
19,025 Added 224.59%
27,496 $321,000
Q4 2020

Feb 10, 2021

BUY
$10.35 - $15.94 $4,957 - $7,635
479 Added 5.99%
8,471 $90,000
Q3 2020

Nov 12, 2020

BUY
$10.24 - $19.58 $81,838 - $156,483
7,992 New
7,992 $97,000
Q2 2020

Aug 13, 2020

SELL
$9.71 - $17.87 $130,929 - $240,959
-13,484 Closed
0 $0
Q1 2020

May 13, 2020

BUY
$5.57 - $10.76 $72,877 - $140,783
13,084 Added 3271.0%
13,484 $145,000
Q2 2019

Aug 09, 2019

BUY
$8.17 - $11.07 $3,268 - $4,428
400 New
400 $4,000
Q1 2019

May 13, 2019

SELL
$9.63 - $13.09 $5,450 - $7,408
-566 Closed
0 $0
Q4 2018

Feb 06, 2019

BUY
$10.53 - $15.54 $168 - $248
16 Added 2.91%
566 $7,000
Q3 2018

Nov 08, 2018

BUY
$15.25 - $17.72 $8,387 - $9,746
550 New
550 $9,000
Q4 2017

Feb 09, 2018

SELL
$13.44 - $22.81 $164,707 - $279,536
-12,255 Closed
0 $0
Q3 2017

Nov 15, 2017

SELL
$19.97 - $22.74 $127,827 - $145,558
-6,401 Reduced 34.31%
12,255 $276,000
Q2 2017

Aug 14, 2017

BUY
N/A
18,656
18,656 $322,000

Others Institutions Holding OSUR

About ORASURE TECHNOLOGIES INC


  • Ticker OSUR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 72,619,104
  • Market Cap $285M
  • Description
  • OraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, and sells oral fluid diagnostic products and specimen collection devices in the United States, Europe, and internationally. It operates in two segments, Diagnostics and Molecular Solutions. The company's principal products include InteliSwab COVID-19 rap...
More about OSUR
Track This Portfolio

Track Group One Trading, L.P. Portfolio

Follow Group One Trading, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.